Clinical Holds for Cell and Gene Therapy Trials: Risks, Impact, and Lessons Learned […]
Read More… from Molecular Therapy: Methods & Clinical Development – Review
Publication Programs: Platform
Molecular Therapy: Methods & Clinical Development – Peer-Reviewed Manuscript
Development of a Gene Edited Next-Generation Hematopoietic Cell Transplant to Enable Acute Myeloid Leukemia Treatment by Solving Off-Tumor Toxicity […]
Read More… from Molecular Therapy: Methods & Clinical Development – Peer-Reviewed Manuscript
ASGCT – 2023 – Poster Presentation 618
Gene Editing and Immunotherapeutic Targeting of ADGRE2/EMR2 to Enable Combinatorial Targeting in Acute Myeloid Leukemia (AML) […]
Keystone Symposia – 2023 – Poster Presentation 3527
Translocation Detection and Quantification Workflow to Characterize CRISPR-Cas Multiplex Edited Hematopoietic Stem and Progenitor Cells (HSPCs) […]
Read More… from Keystone Symposia – 2023 – Poster Presentation 3527
Cell & Gene – White Paper
Leveraging Human Genetics To Advance Cell Therapies For Treatment Of Blood Cancers […]
Rocky Conference – 2022 – Poster Presentation 71
A machine learning approach incorporating germline information improves genotyping of CRISPR-Cas9 gene editing events at single cell resolution […]
Read More… from Rocky Conference – 2022 – Poster Presentation 71
ASH – 2022 – Poster Presentation 4587
Efficient Multiplex Gene Editing of CD33 and CLL-1 in Human Hematopoietic Stem Cells Enables the Potential of Next-Generation Transplants for AML Treatment […]
SITC – 2022 – Poster Presentation P334
Functional Validation of Single Domain Antibody-Derived CD33 Specific CAR-T Cells for the Treatment of Acute Myeloid Leukemia […]
ESGCT – 2022 – Poster Presentation P432
Multiplex deletion of myeloid antigens by base editing in human hematopoietic stem and progenitor cells (HSPCs) enables potential for next generation transplant for acute myeloid leukemia (AML) treatment […]